Indefinite Delivery Contract 36C25022D0006

Award Date 10/1/21
Last Date to Order 9/30/26
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA-VHA) awarded a single-award, indefinite delivery contract to Sofie CO., doing business as Sofie, to provide PET radiopharmaceuticals. The contract includes a base period from April 15, 2022 to April 14, 2025 with a potential value of $676,598.52. Two firm fixed price delivery orders were also awarded against the contract to provide PET radiopharmaceuticals to the VA Western New York...
Sofie CO. has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide radioactive PET tracer isotopes. The single award contract has a potential value of $1,698,000 and period of performance through February 2029. Under the contract, Sofie CO. has received a $339,600 firm fixed price delivery order to supply radioactive PET tracer isotopes for use at the Veterans Affairs Medical Center...
Sofie Co. was awarded an indefinite delivery contract from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide radiopharmaceuticals. The contract has a potential value of $209,760 and period of performance through July 2022. Sofie was issued two firm fixed price delivery orders against the VHA Pharmaceutical Prime Vendor contract totaling $537,032.67 to supply Pylarify Piflufolastat F18 for use in positron emission tomography...
The Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Indefinite Delivery Contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $5,864,170.00 contract provides for the procurement of PYLARIFY F-18 DCFPYL radiopharmaceuticals and related services in support of the VA Saint Louis Health Care System's prostate cancer detection program. The contract is set-aside for small...
The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Sofie CO., doing business as Sofie and subsidiary of Sofie Biosciences, Inc., to provide radiopharmaceutical products and services in support of nuclear medicine diagnostic services for veterans. The single award contract, valued at up to $500,000, has a period of performance from October 1, 2022 through March 31, 2024. Two calls have been issued against the blanket purchase agreement....
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $2,345,668 Firm Fixed Price contract has an ultimate completion date of August 31, 2029 and was awarded on September 1, 2024. The contract is for the delivery of PYLARIFY (piflufolastat F-18) isotopes, which are used for prostate cancer detection through positron emission...
This federal Indefinite Delivery Contract (IDC) award, valued at up to $6,282,459.40, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, which does not have a set-aside designation, is for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection, as well as other molecular diagnostics and related services. Under this IDC, Sofie CO. has...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $1,009,490.10 single-award IDV covers the supply of the F-18 PYLARIFY (piflufolastat F-18) prostate-specific membrane agent radiopharmaceutical and related services from September 2022 through August 2025, with four one-year option periods. Under this IDV, the VA has issued...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 has awarded multiple indefinite delivery contracts and delivery orders to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft (Siemens AG), for the provision of pet radiopharmaceuticals. These specialized medical imaging products, including fluorodeoxyglucose (FDG), Axumin, Amyvid, and Tauvid, are used in positron emission tomography (PET) and computed tomography (CT) scans to diagnose conditions such...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite-delivery/indefinite-quantity contract with a potential value of $358,625 to Petnet Solutions, Inc. for positron emission tomography radiopharmaceuticals. Petnet Solutions is a subsidiary of Siemens Aktiengesellschaft. Four firm fixed price delivery orders were subsequently awarded against the contract to provide radiopharmaceuticals in support of nuclear imaging...
  • 36C25022D0006
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

The Department of Veterans Affairs Veterans Integrated Service Network 10 (VA VISN 10) awarded a single-award indefinite delivery contract to Sofie CO., a subsidiary of Sofie Biosciences, to provide radiopharmaceutical PET imaging products and services. The $1.3 million contract, with a period of performance from October 2021 through September 2026, supports the VA's diagnostics and cancer treatment programs for veterans across the VISN 10 region.

The contract requires Sofie to deliver critical radiopharmaceuticals such as FDG (fluorodeoxyglucose) and NaF (sodium fluoride) PET imaging agents to the Cleveland VA Medical Center on a routine and emergency basis. Sofie will also provide quality control, labeling, and other technical services to ensure the radiopharmaceuticals meet regulatory requirements. This contract vehicle allows the VA to streamline procurement of these specialized products to support its ongoing healthcare services for veterans without the use of any set-asides.

Generated 9/7/24, 10:33 AM